Under typical circumstances, this Series primarily dedicates a minimum of 95% of its net assets to American Depositary Receipts (ADRs) that represent shares of AstraZeneca PLC. It's crucial to understand that the Series will not directly acquire stock in AstraZeneca PLC. ADRs are essentially certificates issued by an American financial institution (a bank or trust company) that confirm ownership of underlying securities from a company based outside the U.